Structures by: Daoui S.
Total: 12
(<i>E</i>)-4-(2,6-Dichlorobenzyl)-6-styrylpyridazin-3(2<i>H</i>)-one
C19H14Cl2N2O
Acta Crystallographica Section E (2021) 77, 1 23-27
a=10.1306(5)Å b=10.7019(6)Å c=15.7749(7)Å
α=90° β=97.715(4)° γ=90°
2-(5-Benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid
C19H16N2O3
Acta Crystallographica Section E (2020) 76, 3 432-437
a=10.5500(8)Å b=9.3679(6)Å c=16.5606(15)Å
α=90° β=93.886(7)° γ=90°
C19H16N2O3
C19H16N2O3
Acta Crystallographica Section E (2020) 76, 3 432-437
a=10.5976(6)Å b=15.5500(7)Å c=10.3731(7)Å
α=90° β=109.120(5)° γ=90°
2-[5-(4-Methylbenzyl)-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl]acetic acid
C20H18N2O3
Acta Crystallographica Section E (2019) 75, 12 1925-1929
a=8.4213(7)Å b=9.0739(9)Å c=12.2238(12)Å
α=106.501(8)° β=92.390(8)° γ=100.750(8)°
6-[(<i>E</i>)-2-(Thiophen-2-yl)ethenyl]-4,5-dihydropyridazin-3(2<i>H</i>)-one
C10H10N2OS
Acta Crystallographica Section E (2019) 75, 12 1880-1883
a=6.9932(5)Å b=16.2916(9)Å c=9.3544(7)Å
α=90° β=110.168(6)° γ=90°
(<i>E</i>)-6-(4-Hydroxy-3-methoxystyryl)-4,5-dihydropyridazin-3(2<i>H</i>)-\ one
C13H14N2O3
Acta Crystallographica Section E (2019) 75, 11 1734-1737
a=6.0828(9)Å b=9.4246(13)Å c=11.1724(16)Å
α=75.838(11)° β=83.099(12)° γ=84.059(11)°
4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2<i>H</i>)-one
C17H14N2O
Acta Crystallographica Section E (2019) 75, 11 1679-1684
a=10.819(3)Å b=11.501(3)Å c=11.187(4)Å
α=90° β=90.93(3)° γ=90°
Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate
C20H16Cl2N2O3
Acta Crystallographica Section E (2019) 75, 11 1679-1684
a=11.2730(13)Å b=12.3808(9)Å c=14.1405(15)Å
α=90° β=92.801(9)° γ=90°
4-Benzyl-2-[2-(4-fluorophenyl)-2-oxoethyl]-6-phenylpyridazin-3(2<i>H</i>)-one
C25H19FN2O2
Acta Crystallographica Section E (2019) 75, 7 1030-1034
a=5.0575(3)Å b=10.0973(7)Å c=38.608(2)Å
α=86.237(5)° β=86.675(5)° γ=88.354(5)°
Ethyl 2-[5-(3-chlorobenzyl)-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl]acetate
C21H19ClN2O3
Acta Crystallographica Section E (2019) 75, 6 892-895
a=8.8410(11)Å b=10.3043(12)Å c=11.3610(12)Å
α=94.801(9)° β=103.596(9)° γ=106.905(9)°
4-(2,6-Dichlorobenzyl)-6-phenylpyridazin-3(2<i>H</i>)-one
C17H12Cl2N2O
Acta Crystallographica Section E (2019) 75, 5 650-654
a=5.8511(6)Å b=12.5544(15)Å c=21.069(2)Å
α=90° β=92.666(8)° γ=90°
4-(4-Methylbenzyl)-6-phenylpyridazin-3(2<i>H</i>)-one
C18H16N2O
Acta Crystallographica Section E (2019) 75, 9 1352-1356
a=5.8479(5)Å b=8.5738(7)Å c=15.2439(12)Å
α=80.693(6)° β=83.147(7)° γ=78.164(7)°